Birchview Capital »

Abivax SA F shares owned by Birchview Capital

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Birchview Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 17k 133.26

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Lam Research Corporation Com New (LRCX)
Solid Biosciences Com New (SLDB)
Intellia Therapeutics (NTLA)
Biodesix
Stoke Therapeutics (STOK)
Encana Corporation (OVV)
Nektar Therapeutics (NKTR)
Corcept Therapeutics Incorporated (CORT)
Neurocrine Biosciences (NBIX)
Prothena Corp SHS (PRTA)
ACADIA Pharmaceuticals (ACAD)
Protagonist Therapeutics (PTGX)
Compass Therapeutics (CMPX)

View all positions for Birchview Capital

Top funds holding Abivax SA F

TCG Crossover Management
Susquehanna International
Citadel Advisors
Darwin Global Management
Helikon Investments
Vestal Point Capital
Jupiter Topco
UBS Group
ADAR1 Capital Management
Morgan Stanley
Caligan Partners
Westfield Capital Management Company
RA Capital Management
Norges Bank Investment Management
Logos Global Management

View all funds holding Abivax SA F